DB

Daniel Beideman

Quality Control Manager at Niagen Bioscience

Daniel Beideman is an experienced professional in the field of biochemistry, currently serving as the Quality Control Manager and Technical Lead at Niagen Bioscience since August 2017, where expertise includes the characterization of small molecules using various analytical techniques such as HPLC, GC, MS, and NMR. Prior to this role, Daniel held multiple positions at the University of Colorado Boulder, including Graduate Research Assistant focused on protein biochemistry and Graduate Teaching Assistant for chemistry and biochemistry courses. Earlier academic achievements include a Bachelor of Science from Lafayette College, where Daniel contributed to organic synthesis research and authored academic exercises for a biochemistry textbook, culminating in a Master of Science in Biochemistry from the same institution.

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Niagen Bioscience

Niagen Bioscience (NASDAQ:NAGE), founded in 1999 and formerly known as ChromaDex, is the global authority on nicotinamide adenine dinucleotide (NAD+), dedicated to advancing healthy-aging science. Our world-renowned scientists collaborate with independent investigators from leading universities and research institutions worldwide to explore the full potential of NAD+, a vital coenzyme found in every cell that declines with age and everyday stressors. Setting the benchmark as the gold standard in scientific rigor, safety, quality, and transparency, Niagen Bioscience is the innovator behind Niagen® (patented nicotinamide riboside, or NR), the most efficient and superior-quality NAD+ booster available. Our ingredient is backed by 35+ human clinical trials and 400+ peer-reviewed studies, making it one of the world's most extensively researched and validated NAD+ precursors. We offer two distinct product lines: Tru Niagen®, the number one healthy-aging NAD+ supplement in the United States*, clinically proven to increase NAD+ levels and help people transform the way they age (available at www.truniagen.com) Niagen® Plus, our premium pharmaceutical-grade NAD+ therapy featuring Niagen™ IV and injectables, available exclusively at clinics with a prescription (www.niagenplus.com) Our robust patent portfolio protects NR and other NAD+ precursors. As pioneers in NAD+ technology, we continue to demonstrate our commitment to excellence, innovation, and integrity through our two California locations (Tustin and Westwood) and our premier research Laboratory & Innovation Center in Longmont, CO. Visit www.niagenbioscience.com for press releases, news, and financial information. Interested in joining our team? Explore career opportunities at https://jobs.lever.co/niagenbioscience +Based on the top selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace. (1/1/24-12/31/24)


Employees

51-200

Links